Chu Swee Yeok
Chairperson & Founding Partner @ August Global Partners
Chu Swee Yeok is a Series B investor at August Global Partners focused on Software and Health Care. Chu Swee Yeok is based out of Singapore and is the Chairperson and Founding Partner of August Global Partners. Swee Yeok previously worked at EDBI Pte Ltd as a CEO, President and Executive Board Director. Chu Swee Yeok attended National University of Singapore.
- Total investments:
- 25
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries Chu Swee Yeok invests in
Stages Chu Swee Yeok invests in
Countries Chu Swee Yeok invests in
Investment Focus
Industry
- Software 6 (24%)
- Health Care 6 (24%)
- Artificial Intelligence 5 (20%)
- Biotechnology 4 (16%)
- Machine Learning 4 (16%)
Stage
- Series B 6 (24%)
- Series C 6 (24%)
- Series A 4 (16%)
- Venture - Series Unknown 3 (12%)
- Series D 2 (8%)
Country
- Singapore 10 (40%)
- United States 6 (24%)
- Taiwan 1 (4%)
- Vietnam 1 (4%)
- Switzerland 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Endowus
|
Endowus is a supplier of financial advice and customized investing services designed to help clients develop their money. The company's services enable investors to access institutional share-class funds at institutional-level fees, charging a single access fee that includes advice, investment, rebalancing, transfers, and brokerage. | $35M / Series C / Aug 09, 2023 | |
Mirxes
|
MiRXES offers discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all. | $50M / Series D / Jul 25, 2023 | |
Biofourmis
|
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effectivesolutions for payers.Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts. | $300M / Series D / Apr 26, 2022 | |
RVAC Medicines
|
RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases. | $140M / Series B / Apr 26, 2022 | |
Hazel Technologies
|
Hazel Technologies develops biotechnology for reducing waste in the agricultural supply chain. Their product development is funded in part by the United States Department of Agriculture (USDA) and their product performance has been validated by 3rd party academic research institutions such as Cornell University. The company provides USDA-funded1-MCP technology conditions the storage atmosphere to reduce respiration rate & increase resistance to ethylene.Hazel Technologies offers horticultural consulting services to growers and shippers, as well as develops new solutions to reduce food waste to improve the fresh produce supply chain. It also provides shelf-life extension technologies and services to combat the global food waste problem and improve profitability for its customers.Hazel Technologies was founded in 2015 and is headquartered in Chicago, Illinois, USA. | Venture - Series Unknown / Jan 21, 2022 | |
Sleek
|
Sleek makes the lives of entrepreneurs and investors easier.They incorporate companies in Singapore & Hong Kong, and help them manage their governance, accounting and tax matters using technology. They launched their services in Singapore in May 2017 because they were frustrated at how slow and paper-based the incorporation and companyregistration process was.Since their launch, they have incorporated hundreds of happy companies, offering 100% digital incorporation, company secretary, and accounting services in Singapore and Hong Kong. | $11M / Series A / Dec 17, 2021 | |
bolttech
|
Bolttech is an InsurTech company developing an AI-based point of sale insurance platform to offer a technology-enabled ecosystem for protection and insurance. Its platform also offers device protection, travel, motor, property and life insurance, and digital insurance to consumers. | $67.2M / Series A / Dec 06, 2021 | |
Ember Technologies
|
Ember is a design-led temperature control brand and technology platform, whose mission is to revolutionize the way people eat, drink and live. Founded by inventor and serial entrepreneur Clay Alexander, Ember creates, designs, and develops temperature control products that offer people complete customization.Named one of TIME magazine’s BestInventions, the award-winning temperature control Ember Travel Mug² and Ember Mug² are the most advanced coffee mugs on the market, allowing individuals to set and maintain their preferred drinking temperature for hot beverages.Ember’s temperature control smart mugs are available in top retailers such as Best Buy, Apple, Williams Sonoma, Costco, and Target.Ember is applying its innovative temperature control technology to new categories, including healthcare and infant feeding. | $23.5M / Series E / Dec 01, 2021 | |
|
Endowus
|
Endowus is a supplier of financial advice and customized investing services designed to help clients develop their money. The company's services enable investors to access institutional share-class funds at institutional-level fees, charging a single access fee that includes advice, investment, rebalancing, transfers, and brokerage. | $25.6M / Venture - Series Unknown / Nov 29, 2021 | |
|
bolttech
|
Bolttech is an InsurTech company developing an AI-based point of sale insurance platform to offer a technology-enabled ecosystem for protection and insurance. Its platform also offers device protection, travel, motor, property and life insurance, and digital insurance to consumers. | $30M / Series A / Sep 21, 2021 | |
| See all 25 investments → | |||
Co-Investors
About August Global Partners
August Global Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Basil Lui
Founding Partner
|
|||
|
Chu Swee Yeok
Chairperson & Founding Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chu Swee Yeok invest in?
Chu Swee Yeok invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Series B and Series C stage. Most of the 25 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chu Swee Yeok last invest?
The most recent investment recorded for Chu Swee Yeok closed in Aug 2023. Shizune tracks 25 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
